Related Experiment Videos

Assessment of cellular localization of the thromboxane A2 receptor by immunocytochemistry

S C Blackman¹, C Borg, D C Yeomans

¹Department of Pharmacology, College of Medicine, University of Illinois, Chicago, USA.

Methods in Molecular Biology (Clifton, N.J.)

|May 27, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trial.

ESMO gastrointestinal oncology·2026

Concomitant proton pump inhibitors and capecitabine-based chemoradiotherapy in rectal cancer: an ancillary study from the PRODIGE 23 trial.

ESMO gastrointestinal oncology·2026

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age.

Frontiers in immunology·2023

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.

British journal of cancer·2022

Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins.

Scientific reports·2020

See all related articles